Qualigen Therapeutics Inc... (QLGN)
NASDAQ: QLGN
· Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 05:08 PM EDT
Qualigen Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2021 |
|---|---|
| License Revenue Revenue | 632K |
| License Revenue Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Jun 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.49M | 1.02M | 1.15M | 986.48K | 1.05M | 958.28K | 1.34M | 2.84M | 1.91M | 2.93M | 2.86M | 2.97M | 3.04M | 3.28M | 2.89M | 3.09M | 3.01M | 2.58M | 2.76M | 2.07M | 2.21M | 4,570.9B | 277.2K | 371.41K | 1.15M | 1.47M | 1.14M | 1.69M | 1.13M | 1.41M | 1.05M | 1.14M | 1.17M | 1.35M | 1.09M | 1.21M | 1.24M | 1.56M | 2M |
| Selling, General, and Administrative Revenue Growth | +145.05% | -11.10% | +16.08% | -5.84% | +9.32% | -28.31% | -52.85% | +48.16% | -34.58% | +2.35% | -3.64% | -2.34% | -7.49% | +13.73% | -6.51% | +2.56% | +16.59% | -6.54% | +33.56% | -6.38% | -100.00% | +1648982463.96% | -25.37% | -67.80% | -21.39% | +28.19% | -32.14% | +49.83% | -20.16% | +34.01% | -8.04% | -2.31% | -13.11% | +23.49% | -9.55% | -2.27% | -20.63% | -22.27% | n/a |
| Research and Development Revenue | 33.17K | -44.94K | 123.43K | 754.29K | 364.38K | 1.31M | 1.44M | 1.33M | 2.12M | 1.78M | 1.69M | 1.51M | 1.86M | 1.63M | 2.08M | 4.51M | 3.5M | 1.85M | 870.88K | 597.35K | 1.82K | 6,127B | 201.41K | 687.07K | 3.57M | 5.19M | 3.46M | 1.87M | 849.68K | 752.29K | 915.27K | 774.48K | 432.15K | 6.18M | 2.35M | 2.88M | 1.88M | 1.51M | 47.98K |
| Research and Development Revenue Growth | -173.80% | -136.41% | -83.64% | +107.00% | -72.21% | -9.05% | +8.67% | -37.47% | +19.32% | +5.33% | +12.07% | -19.23% | +14.71% | -21.97% | -53.79% | +28.84% | +89.37% | +112.19% | +45.79% | +32721.15% | -100.00% | +3042037304.63% | -70.69% | -80.78% | -31.06% | +49.88% | +84.89% | +120.23% | +12.95% | -17.81% | +18.18% | +79.21% | -93.01% | +163.13% | -18.46% | +52.99% | +25.10% | +3037.16% | n/a |